2Snokusare S. K, Kaul C. L, Ramarao P. Demential of Alzheimer's disease and other neurodegenerative disorders- memantine, a new hope pharmacological[J]. Pharmacological Research, 2005, 51(1): 1-17.
3Terry R. D, Masliah E. Physical basis of cognitive alterationsin Alzheimer's disease: synapse loss is the major cor- relate of cognitive impairment[J]. Ann Neurol, 1991, 30: 572-580.
4Kwon H. C, Jensen P. R, Fenical W. Marinomycins A. D, antitumor-antibiotics of a new structure class from a marine actinomycete of the recently discovered genus 'marinispom'[J]. J Am Chem Soe, 2006, 128(5): 1622-1632.
5Snokusare S K, Kaul C L, Ramarao P. Demential of Alzheimer' s disease and other neurodegenerative disorders- memantine, a new hope pharmacological [ J]. Pharmaco- logical Research, 2005, 51 ( 1 ) : 1 - 17.
6DeKosky S T, Scheff S W. Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity [J]. Annals of Neurology, 1990, 27(5): 457- 464.
7Terry R D, Masliah E, Salmon D P, et al. Physical basis of cognitive alterations in alzheimer disease : Synapse loss is the major correlate of cognitive impairment [ J]. Annals of Neurology, 1991, 30 (4) : 572 - 580.
8Lleo A, Greenberg S M, Growdon J H. Current pharmaco- therapy for alzheimer' s disease [ J ]. Annual Review of Medicine, 2006, 57:513-533.
9WANG Y, XU L, REN W. Bioactive metabolites from Chaetomium globosum L18, an endophytic fungus in the medicinal plant Curcuma wenyujin [ J ]. Phytomedicine, 2012, 19(3) : 364 -368.
10Tamura K, Dudley J, Nei M, et al. MEGA4: Molecular evolutionary genetics analysis (MEGA) software version 4.0[J]. Molecular Biology and Evolution Tempe, 2007,24(8): 1 596-1 599.
